Alzheimer and Parkinson diagnoses in progranulin null mutation carriers in an extended founder family.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Archives of Neurology

• Publication date

  2007-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1001/ARCHNEUR.64.10.1436PMID 17923627
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Diagnostic performance of a CSF-biomarker panel in autopsy-confirmed dementia.

  2008cited by this paper
• Cerebrospinal fluid tau/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults.

  2007cited by this paper
• Mutations other than null mutations producing a pathogenic loss of progranulin in frontotemporal dementia

  2007cited by this paper
• Neuropathologic Heterogeneity in HDDD1: A Familial Frontotemporal Lobar Degeneration With Ubiquitin-positive Inclusions and Progranulin Mutation

  2007cited by this paper
• Progranulin and frontotemporal lobar degeneration

  2007cited by this paper
• Dose dependent effect of APOE ε4 on behavioral symptoms in frontal lobe dementia

  2006cited by this paper
• Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17

  2006cited by this paper
• Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21

  2006cited by this paper
• Dose dependent effect of APOE epsilon4 on behavioral symptoms in frontal lobe dementia.

  2006influential reference
• HDDD2 is a familial frontotemporal lobar degeneration with ubiquitin‐positive, tau‐negative inclusions caused by a missense mutation in the signal peptide of progranulin

  2006cited by this paper
• Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration.

  2006cited by this paper
• A Belgian ancestral haplotype harbours a highly prevalent mutation for 17q21-linked tau-negative FTLD.

  2006cited by this paper
• Characterization of Ubiquitinated Intraneuronal Inclusions in a Novel Belgian Frontotemporal Lobar Degeneration Family

  2006cited by this paper
• novoSNP, a novel computational tool for sequence variation discovery.

  2005cited by this paper
• The Middelheim Frontality Score: a behavioural assessment scale that discriminates frontotemporal dementia from Alzheimer's disease

  2005cited by this paper
• Frontotemporal dementia.

  2005cited by this paper
• Anterior temporal laterality in primary progressive aphasia shifts to the right

  2005cited by this paper
• Tau is central in the genetic Alzheimer-frontotemporal dementia spectrum.

  2005cited by this paper
• Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study.

  2003cited by this paper
• Progranulin (granulin-epithelin precursor, PC-cell-derived growth factor, acrogranin) mediates tissue repair and tumorigenesis

  2003influential reference
• Tau negative frontal lobe dementia at 17q21: significant finemapping of the candidate region to a 4.8 cM interval

  2002cited by this paper
• Case–control study of environmental risk factors for Parkinson's disease in Belgium

  2002influential reference
• Progression of parkinsonism and loss of cognitive function in Alzheimer disease.

  2000cited by this paper
• Human Upf proteins target an mRNA for nonsense-mediated decay when bound downstream of a termination codon.

  2000cited by this paper
• Improved discrimination of AD patients using β-amyloid(1-42) and tau levels in CSF

  1999cited by this paper
• Frontotemporal dementia

  1999cited by this paper
• A population-based study of familial Alzheimer disease: linkage to chromosomes 14, 19, and 21.

  1994cited by this paper
• Intellectual Impairment in Parkinson's Disease: Clinical, Pathologic, and Biochemical Correlates

  1988cited by this paper
• Clinical diagnosis of Alzheimer's disease

  1984cited by this paper

• ASO-mediated knock-down of GPNMB in mutant-GRN and in Grn-deficient peripheral myeloid cells disrupts lysosomal function and immune responses

  2025cites this paper
• Pathogenic or Likely Pathogenic GRN Variants Are Found in 0.1% of Parkinson's Disease Patients.

  2025cites this paper
• How close is autophagy-targeting therapy for Alzheimer's disease to clinical use? A summary of autophagy modulators in clinical studies

  2025cites this paper
• The role of endolysosomal progranulin and TMEM106B in neurodegenerative diseases

  2025cites this paper
• A novel c.1468 G > A GRN mutation causes frontotemporal dementia in a Chinese Han family

  2025cites this paper
• Summarizing the Role of Selected Adipokines in Parkinson’s Disease: What Is Known About Leptin, Adiponectin, Resistin, Visfatin, and Progranulin in Neurodegeneration?

  2025cites this paper
• Progranulin function and regulation in the CNS.

  2025cites this paper
• Risk of Alzheimer's disease in Down syndrome: Insights gained by multi‐omics

  2025cites this paper
• Targeting Granulin Haploinsufficiency in Frontotemporal Dementia: From Genetic Mechanisms to Therapeutics

  2025cites this paper
• Reduced progranulin increases tau and α-synuclein inclusions and alters mouse tauopathy phenotypes via glucocerebrosidase

  2024cites this paper
• Investigating the role and regulation of GPNMB in progranulin-deficient macrophages

  2024cites this paper
• Investigating the Role and Regulation of GPNMB in Progranulin-deficient Macrophages

  2024cites this paper
• Genetics and Neuropathology of Neurodegenerative Dementias

  2024cites this paper
• SorCS2 binds progranulin to regulate motor neuron development.

  2023cites this paper
• Characterization of Progranulin Gene Mutations in Portuguese Patients with Frontotemporal Dementia

  2023cites this paper
• Progranulin and GPNMB: interactions in endo-lysosome function and inflammation in neurodegenerative disease

  2023cites this paper
• Progranulinopathy: A diverse realm of disorders linked to progranulin imbalances.

  2023cites this paper
• Regulation of extracellular progranulin in medial prefrontal cortex

  2023cites this paper
• GRN Mutations Are Associated with Lewy Body Dementia

  2022cites this paper
• Case analysis of early-onset Alzheimer's disease associated with TBK1 p.Tyr235Phe gene mutation

  2022cites this paper
• Is Exposure to BMAA a Risk Factor for Neurodegenerative Diseases? A Response to a Critical Review of the BMAA Hypothesis

  2021cites this paper
• Recognition memory and divergent cognitive profiles in prodromal genetic frontotemporal dementia.

  2021cites this paper
• C9orf72 deficiency promotes microglial-mediated synaptic loss in aging and amyloid accumulation.

  2021cites this paper
• Microglia and astrocyte involvement in neurodegeneration and brain cancer

  2021cites this paper
• AZP2006, a new promising treatment for Alzheimer’s and related diseases

  2021cites this paper
• FTD-PSP is an Unusual Clinical Phenotype in A Frontotemporal Dementia Patient with A Novel Progranulin Mutation

  2021cites this paper
• Tweaking Progranulin Expression: Therapeutic Avenues and Opportunities

  2021cites this paper
• A New Neurovascular Panel Discriminates Between Patients with Type 2 Diabetes Mellitus with Cognitive Impairment and Cognitive Impairment Alone

  2020cites this paper
• Homozygous and compound heterozygous rare variants in VPS13C contribute to Lewy body diseases

  2020cites this paper
• Isolated parkinsonism is an atypical presentation of GRN and C9orf72 gene mutations.

  2020cites this paper
• Progranulin and Central Nervous System Disorders

  2019cites this paper
• Impaired β-glucocerebrosidase activity and processing in frontotemporal dementia due to progranulin mutations

  2019influential citation
• Genetics of neurodegenerative dementias in ten points – what can a neurologist expect from molecular genetics?

  2019cites this paper
• Cysteine-rich granulin-3 rapidly promotes amyloid-β fibrils in both redox states.

  2019cites this paper
• PGRN and Neurodegenerative Diseases Other Than FTLD

  2019cites this paper
• The Missing Heritability of Sporadic Frontotemporal Dementia: New Insights from Rare Variants in Neurodegenerative Candidate Genes

  2019cites this paper
• Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study

  2019cites this paper
• Progranulin and Frontotemporal Lobar Degeneration

  2019cites this paper
• Molecular mechanisms of the co‐deposition of multiple pathological proteins in neurodegenerative diseases

  2018cites this paper
• Chitinase-3-like Protein 1: A Progranulin Downstream Molecule and Potential Biomarker for Gaucher Disease

  2018cites this paper
• Clinical variability and onset age modifiers in an extended Belgian GRN founder family.

  2018cites this paper
• Genetic Variation in Genes Underlying Diverse Dementias May Explain a Small Proportion of Cases in the Alzheimer’s Disease Sequencing Project

  2018cites this paper
• Pleiotropic Effects of Variants in Dementia Genes in Parkinson Disease

  2018cites this paper
• Genetic screening in early-onset dementia patients with unclear phenotype: relevance for clinical diagnosis.

  2018cites this paper
• Genotype–phenotype links in frontotemporal lobar degeneration

  2018cites this paper
• Genetic Risk Factors for Sporadic Frontotemporal Dementia

  2018cites this paper
• Gene mutations in a Han Chinese Alzheimer's disease cohort

  2018cites this paper
• Peripheral GRN mRNA and Serum Progranulin Levels as a Potential Indicator for Both the Presence of Splice Site Mutations and Individuals at Risk for Frontotemporal Dementia

  2018cites this paper
• Possible concurrence of TDP‐43, tau and other proteins in amyotrophic lateral sclerosis/frontotemporal lobar degeneration

  2018cites this paper
• Modifiers of GRN-Associated Frontotemporal Lobar Degeneration.

  2017cites this paper
• Neuroinflammation in Amyotrophic Lateral Sclerosis: Role of Redox (dys)Regulation

  2017cites this paper
• Genetic Heterogeneity of Alzheimer’s Disease: Embracing Research Partnerships

  2017cites this paper
• State of Play in Alzheimer’s Disease Genetics

  2017cites this paper
• Frontotemporal Dementia due to the Novel GRN Arg161GlyfsX36 Mutation

  2017cites this paper
• Progranulin: a new avenue towards the understanding and treatment of neurodegenerative disease

  2017cites this paper
• Progranulin haploinsufficiency reduces amyloid beta deposition in Alzheimer’s disease model mice

  2017cites this paper
• Angiogenin Prevents Progranulin A9D Mutation-Induced Neuronal-Like Cell Apoptosis Through Cleaving tRNAs into tiRNAs

  2017cites this paper
• Accumulation of multiple neurodegenerative disease-related proteins in familial frontotemporal lobar degeneration associated with granulin mutation

  2017cites this paper
• Disorder in Cysteine-Rich Granulin-3 and Its Implication in Alzheimer Disease

  2017cites this paper
• Disulfide bonds and disorder in granulin‐3: An unusual handshake between structural stability and plasticity

  2017cites this paper
• Molecular Genetics of Neurodegenerative Dementias.

  2017cites this paper
• Opposing effects of progranulin deficiency on amyloid and tau pathologies via microglial TYROBP network

  2017cites this paper
• Fully reduced granulin-B is intrinsically disordered and displays concentration-dependent dynamics.

  2016influential citation
• Reduced secretion and altered proteolytic processing caused by missense mutations in progranulin.

  2016cites this paper
• Application of Systems Theory in Longitudinal Studies on the Origin and Progression of Alzheimer's Disease.

  2016cites this paper
• Novel PSEN1 mutations (H214N and R220P) associated with familial Alzheimer's disease identified by targeted exome sequencing.

  2016cites this paper
• Frontotemporal dementia-related gene mutations in clinical dementia patients from a Chinese population

  2016cites this paper
• Impaired protein degradation in FTLD and related disorders.

  2016cites this paper
• Modelling Neurodegenerative Diseases Using Human Pluripotent Stem Cells

  2016cites this paper
• Targeting microglia for the treatment of Alzheimer's Disease

  2016influential citation
• Progranulin and Amyloid-β Levels: Relationship to Neuropsychology in Frontotemporal and Alzheimer’s Disease

  2015cites this paper
• Association of progranulin polymorphism rs5848 with neurodegenerative diseases: a meta-analysis

  2015cites this paper
• The Progranulin Cleavage Products, Granulins, Exacerbate TDP-43 Toxicity and Increase TDP-43 Levels

  2015cites this paper
• Progranulin Reduction Is Associated With Increased Tau Phosphorylation in P301L Tau Transgenic Mice

  2015cites this paper
• The genetic landscape of Alzheimer disease: clinical implications and perspectives

  2015cites this paper
• Cerebrospinal Fluid Biomarkers in Familial Forms of Alzheimer's Disease and Frontotemporal Dementia

  2015cites this paper
• Phenotypic Heterogeneity of Monogenic Frontotemporal Dementia

  2015cites this paper
• Progranulin in neurodegenerative disease.

  2014cites this paper
• Alzheimer's disease genetics: from the bench to the clinic.

  2014cites this paper
• Progranulin Gene Delivery Protects Dopaminergic Neurons in a Mouse Model of Parkinson’s Disease

  2014cites this paper
• Significance and limitation of the pathological classification of TDP‐43 proteinopathy

  2014cites this paper
• Progranulin and a Five Transmembrane Domain-Containing Receptor-like Gene Are the Key Components in Receptor Activator of Nuclear Factor κB (RANK)-dependent Formation of Multinucleated Osteoclasts*

  2014cites this paper
• Common pathobiochemical hallmarks of progranulin-associated frontotemporal lobar degeneration and neuronal ceroid lipofuscinosis

  2014cites this paper
• Alzheimer’s Disease and Frontotemporal Lobar Degeneration: Mouse Models

  2014cites this paper
• C9orf72 G4C2 repeat expansions in Alzheimer's disease and mild cognitive impairment.

  2013cites this paper
• C9ORF72 Hexanucleotide Repeat Number in Frontotemporal Lobar Degeneration: A Genotype-Phenotype Correlation Study

  2013cites this paper
• Cross-talk between insulin and serotonin signaling in the brain : Involvement of the PI3K/Akt pathway and behavioral consequences in models of insulin resistance

  2013cites this paper
• Progranulin Peripheral Levels as a Screening Tool for the Identification of Subjects with Progranulin Mutations in a Portuguese Cohort

  2013cites this paper
• C9orf72 hexanucleotide repeat expansions in clinical Alzheimer disease.

  2013influential citation
• Genetic factors in frontotemporal dementia: A review

  2013cites this paper
• Progranulin Deficiency Promotes Post-Ischemic Blood–Brain Barrier Disruption

  2013cites this paper
• Promoter DNA methylation regulates progranulin expression and is altered in FTLD

  2013cites this paper
• A Shift to Organismal Stress Resistance in Programmed Cell Death Mutants

  2013cites this paper
• Genetic insights in Alzheimer's disease.

  2013cites this paper
• Psychotropic Drug Effects on Gene Transcriptomics Relevant to Alzheimer Disease

  2012cites this paper
• C9ORF72 repeat expansions and other FTD gene mutations in a clinical AD patient series from Mayo Clinic.

  2012cites this paper
• Serum Progranulin Levels in Patients with Frontotemporal Lobar Degeneration and Alzheimer's Disease: Detection of GRN Mutations in a Spanish Cohort

  2012influential citation
• Progranulin: an emerging target for FTLD therapies.

  2012cites this paper
• Alternative splicing of mRNA in the molecular pathology of neurodegenerative diseases.

  2012cites this paper
• Rare Variants in APP, PSEN1 and PSEN2 Increase Risk for AD in Late-Onset Alzheimer's Disease Families

  2012cites this paper